SCHEMBL24252036

SCHEMBL24252036

CCNC(=O)c1cccc(C(C)(C)C)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 3/20 0.47
CTSK P43235 2/20 0.47
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
TAS1R2 Q8TE23 1/20 0.43
LMNA P02545 1/20 0.42
BRD4 O60885 1/20 0.42
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
HPGD P15428 2/20 0.41
ITGB1 P05556 1/20 0.40
ITGA4 P13612 1/20 0.40
CXCR2 P25025 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13753318 0.86 CTSS (0.62) CTSSCTSKLMNASLC6A9
SCHEMBL7223846 0.83 L3MBTL1 (0.49) LMNABRD4ALDH1A1KMT2AL3MBTL1
SCHEMBL24252064 0.82 CTSS (0.47) CTSSCTSKTAS1R3TAS1R1TAS1R2
SCHEMBL4158170 0.80 TAS1R3 (0.64) TAS1R3TAS1R1TAS1R2LMNAALDH1A1
SCHEMBL24252034 0.79 NR1H4 (0.58) CTSSLMNAALDH1A1KMT2AL3MBTL1
SCHEMBL13841435 0.79 TAS1R3 (0.50) TAS1R3TAS1R1TAS1R2LMNABRD4
SCHEMBL7217875 0.78 ALDH1A1 (0.50) ALDH1A1HPGDITGB1ITGA4SLC6A9
SCHEMBL11653801 0.78 P2RX7 (0.57) TAS1R3TAS1R1TAS1R2LMNABRD4
SCHEMBL22059502 0.78 TAS1R3 (0.45) TAS1R3TAS1R1TAS1R2LMNABRD4
SCHEMBL13145651 0.76 TSHR (0.57) CTSSCTSKLMNAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof MAPK11, WEE1, NOS1 CTSS 4371/4885CTSK 4541/4885TAS1R3 4830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.